Eli Lilly, Incyte arthritis drug meets endpoint in late-stage trial

Drug proves effective for patients who had previously had inadequate response to conventional therapies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.